Question-and-Answer Session
Operator
(Operator Instructions) Our first question comes from the line of Ernest Andberg of Felt & Company; please proceed.
Shaun Vincent - Feltl & Company
Hi everyone this is Shaun Vincent for Ernest Anderg couple of things he wanted to just ask, can you provide any insight into the CMS Medicare physician fee schedule reimbursement?
Stryker Warren, Jr.
We wish we could. We neither know when it’s going to be published nor do we know what the final rule is going to look like, and again our expectation is that this will be across many of the specialties, and we simply don’t know when we will have those specifics.
Shaun Vincent - Feltl & Company
Okay, and then can you provide any update on the Boston Scientific recall, and whether or not this has impacted any results?
Stryker Warren, Jr.
In the Boston Scientific earnings call, the CEO indicated that they expect to be back in the market in the fourth quarter and there was no more specificity in that.
With respect to the impact, we have pursued the low energy customer all along on the basis that from a clinical standpoint we can demonstrate through our data superior our technology and outcomes. So dating well back, we have targeted the low energy competitor, no doubt as I shared the fact that they have taken their product out of the market served as an accelerant but we had a very significant quarter just sort of on our core business.
Shaun Vincent - Feltl & Company
Okay, thank you very much.
Operator
(Operator instructions) Our next question comes from the line of Larry Hemowich [ph] of HMPC please proceed.
Larry Hemowich - HMPC
Hey Stryker good afternoon.
Stryker Warren, Jr.
Larry
Larry Hemowich - HMPC
Greetings from sunny California. I wanted to ask you, when you look at the sales growth, would you say that you are success this quarter reflects opening up new accounts or more opening or more expanding the accounts that currently do business that are doing more and more cases?
Stryker Warren, Jr.
It’s all of the above, and the way I would describe that is, that we have with a sales force that I think has matured significantly been able to work more broadly in respective territories, and I think we have also been able to with discussions about patient selection and the like, certainly work with customers to increase utilization.
- To read the full transcript on Seeking Alpha, click here »
